Ocuphire Pharma (OCUP.Q), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for treatment of several eye disorders, announced today that its VEGA-1 Phase 2 clinical trial…
Latest News
Are stock markets about to crash hard?
Revive Therapeutics (RVV.CN) announces FDA acceptance of meeting request
Top 5 Gainers and Losers: LAC.TO, WEED.TO, OML.V
BC Bud Corp (BCBC.C) breathes new life into the cannabis space, up 3x in two months
Top 5 Gainers and Losers: TMQ.TO, GLM.CN, AGMR.V
Standard Uranium (STND.V) reports on exploration at Sun Dog Project